Insights

Federal Regulatory Update from 340B to Drug Pricing

For more information about this blog post, please contact Ryan L. O’Neill or Labinot Alexander Berlajolli. CMS Rolls Out...

New Federal Court Ruling On EKRA and Commission-Based Compensation With Sales Agents

For more information about this blog post, please contact Ryan L. O’Neill or Labinot Alexander Berlajolli. Case law...

CMS Enhancing Oversight of Poor Performing Nursing Homes

For more information about this blog post, please contact  Ryan L. O’Neill or Labinot Alexander Berlajolli. The Centers...

Behavioral Health Integration, 340B Litigation, and Medicare Advantage Plans

For more information about this blog post, please contact Ryan L. O’Neill or Labinot Alexander Berlajolli. HHS Releases...

Litigation Regarding Overseas Telemedicine and Medicare Recoupment Determinations

For more information about this blog post, please contact Ryan L. O’Neill or Labinot Alexander Berlajolli. Overseas Telemedicine Denied...

New Jersey Regulatory Update Part 5

This fifth entry to our 2022 Regulatory Update further reviews regulatory changes published this year through the...

New Jersey Regulatory Update: Part 4

Part 4 of our Regulatory Update focuses on vaccine administration, expanding who can prescribe Narcan, among others....

New Jersey Regulatory Update: Part 3

Part 3 of our New Jersey Regulatory Update continues to review regulatory changes published earlier this year...

New Jersey Regulatory Update: Part 2

As we continue to focus on regulations, Part 2 of our New Jersey Regulatory Update focuses on...